Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7702704rdf:typepubmed:Citationlld:pubmed
pubmed-article:7702704lifeskim:mentionsumls-concept:C0038454lld:lifeskim
pubmed-article:7702704lifeskim:mentionsumls-concept:C0017462lld:lifeskim
pubmed-article:7702704lifeskim:mentionsumls-concept:C0265101lld:lifeskim
pubmed-article:7702704lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7702704lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:7702704lifeskim:mentionsumls-concept:C0918012lld:lifeskim
pubmed-article:7702704lifeskim:mentionsumls-concept:C0526064lld:lifeskim
pubmed-article:7702704pubmed:issue2-3lld:pubmed
pubmed-article:7702704pubmed:dateCreated1995-5-8lld:pubmed
pubmed-article:7702704pubmed:abstractTextWe investigated the effect of beraprost sodium (BPS), a new prostacyclin analog, on behavioral and neuropathological changes induced by a 10-min occlusion of the left carotid artery in gerbils. Gerbils were treated orally with BPS (1-100 micrograms/kg) 30 min before occlusion. Pathological evaluation of neural damage in the CA1 region of the hippocampus was performed 7 d after the ischemic insults. In the symptomatic group, in which the stroke index score was > 10, symptomatic behaviors, such as head cocked, splayed out hind limb, circling, and various similar behaviors, were observed. Pathologically, almost all CA1 neurons were destroyed 7 d after ischemia in the symptomatic group. BPS improved the stroke index during ischemia and neuropathological changes 7 d later, with statistical significant improvement occurring at a dose of 100 micrograms/kg.lld:pubmed
pubmed-article:7702704pubmed:languageenglld:pubmed
pubmed-article:7702704pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7702704pubmed:citationSubsetIMlld:pubmed
pubmed-article:7702704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7702704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7702704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7702704pubmed:statusMEDLINElld:pubmed
pubmed-article:7702704pubmed:issn1044-7393lld:pubmed
pubmed-article:7702704pubmed:authorpubmed-author:MatsudaSSlld:pubmed
pubmed-article:7702704pubmed:authorpubmed-author:UenoSSlld:pubmed
pubmed-article:7702704pubmed:authorpubmed-author:EndohTTlld:pubmed
pubmed-article:7702704pubmed:authorpubmed-author:MiyauchiYYlld:pubmed
pubmed-article:7702704pubmed:issnTypePrintlld:pubmed
pubmed-article:7702704pubmed:volume23lld:pubmed
pubmed-article:7702704pubmed:ownerNLMlld:pubmed
pubmed-article:7702704pubmed:authorsCompleteYlld:pubmed
pubmed-article:7702704pubmed:pagination137-43lld:pubmed
pubmed-article:7702704pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:meshHeadingpubmed-meshheading:7702704-...lld:pubmed
pubmed-article:7702704pubmed:articleTitleEffect of beraprost sodium (BPS) on the postischemic neuropathological changes and stroke index after left carotid artery occlusion in gerbils.lld:pubmed
pubmed-article:7702704pubmed:affiliationBasic Research Laboratories, Toray Industries Inc., Kanagawa, Japan.lld:pubmed
pubmed-article:7702704pubmed:publicationTypeJournal Articlelld:pubmed